Add BrightSurf on Google Email

Johns Hopkins Medicine


Adding blood pressure drug to standard antibiotics speeds up TB treatment

Researchers at Johns Hopkins Medicine found that a blood pressure medication speeds up TB treatment in mice, potentially making it easier for infected people to complete their therapy. The study suggests verapamil, commonly used to treat high blood pressure and headaches, could be an effective add-on therapy when combined with standard...

SourceJohns Hopkins Medicine·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 29, 2013

Therapeutic eye injections may be needed less often

Researchers have created a new drug-delivery strategy using a biodegradable coating that prolongs the effectiveness of an eye medication for macular degeneration. This innovation could significantly reduce the frequency of injections needed, potentially changing the standard of care from monthly to once or twice a year.

SourceJohns Hopkins Medicine·JournalBiomaterials·DateAug 19, 2013

There's life after radiation for brain cells

Researchers at Johns Hopkins Medicine have discovered that neural stem cells can resist radiation and regenerate after damage, potentially restoring lost function in brain cancer patients and individuals with conditions like MS and PD. The findings may lead to new treatments for brain trauma and strokes.

SourceJohns Hopkins Medicine·JournalStem Cells·DateAug 12, 2013

Minimally invasive stents show some advantage over bypass in opening blocked leg arteries

A small study found that patients who received minimally invasive stents had a 31% risk of needing another procedure within 24 months, compared to 54% for those who received bypass surgery. The researchers hope to confirm these findings with further study and develop guidelines for determining when a stent is likely to be best.

SourceJohns Hopkins Medicine·JournalJournal of Vascular Surgery·DateAug 6, 2013

HIV answers raise new ethical questions

Experts warn that widespread use of Truvada for HIV prevention may lead to unintended consequences, including increased transmission of other STIs. Daily dosing, safer sex counseling, and regular testing are crucial for successful PrEP implementation.

SourceJohns Hopkins Medicine·JournalJAIDS Journal of Acquired Immune Deficiency Syndromes·DateJul 31, 2013

Cost of treating dizziness in the emergency room soars

A new study finds that half a billion dollars could be saved annually by using bedside physical exams to identify patients who truly need imaging tests instead of routine head CT scans. Emergency room physicians can confidently diagnose benign inner-ear disorders, freeing up resources for those who need stroke diagnosis.

SourceJohns Hopkins Medicine·JournalAcademic Emergency Medicine·DateJul 17, 2013

Researchers step closer to custom-building new blood vessels

Researchers at Johns Hopkins Medicine have successfully grown new blood vessels from pluripotent stem cells and transplanted them into mice, a crucial step towards developing personalized treatments. The new technique could enable genetically matched blood vessels that are less likely to be rejected by patients' immune systems.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateJul 16, 2013

Self-perpetuating signals may drive tumor cells to spread

A team of international researchers has identified a self-perpetuating signaling circuit in connective tissue cells that allows them to form a front and back and propel themselves in a particular direction. This propulsion is similar to the movement used by tumor cells to invade healthy tissue during cancer metastasis.

SourceJohns Hopkins Medicine·JournalMolecular Biology of the Cell·DateJul 16, 2013

Use redistricting maps to make organ allocation more equitable, Johns Hopkins researchers advocate

Researchers at Johns Hopkins Medicine have created a new model to allocate organs from deceased donors more equitably. The model uses mathematical formulas similar to those used in redistricting maps to analyze supply and demand factors, reducing geographic disparities by half and significantly decreasing waitlist deaths.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Transplantation·DateJul 11, 2013

Don't worry, be healthy

Researchers found that participants with cheerful temperaments had a one-third reduction in coronary events, with those at highest risk experiencing nearly a 50% decrease. The study's findings suggest a general sense of well-being can have an actual effect on disease and may lead to better health outcomes.

Tumor-suppressor Protein Gives Up Its Secrets

Researchers at Johns Hopkins University have discovered that reversible chemical tags attached to the PTEN protein can regulate its activity. When these phosphate groups are bound, PTEN becomes inactive, suppressing cell division and migration. This finding may lead to new options for drug design to keep PTEN working.

Hold the medicinal lettuce

A study by Johns Hopkins Medicine reveals that reported plant genetic material entering human blood may be a false positive, contradicting previous research from Nanjing University. The team used advanced techniques to detect microRNAs in macaques' blood and found highly variable results.

SourceJohns Hopkins Medicine·JournalRNA Biology·DateJun 26, 2013

Respect may be the key to stopping patient 'no shows'

Research suggests that improved training in communication and interpersonal skills may help improve health, immune function, and reduce the spread of HIV. Patients who feel respected by their physicians are more likely to keep scheduled appointments and adhere to medical regimens.

SourceJohns Hopkins Medicine·JournalJAIDS Journal of Acquired Immune Deficiency Syndromes·DateJun 18, 2013

Evidence mounts that 4 lifestyle changes will protect heart, reduce your risk of death

A large study found that adopting four lifestyle behaviors - a Mediterranean-style diet, regular exercise, maintaining a normal weight, and not smoking - can significantly reduce the risk of coronary heart disease and mortality. The researchers found an 80% lower death rate over an eight-year period among participants who adopted all f...

SourceJohns Hopkins Medicine·JournalAmerican Journal of Epidemiology·DateJun 3, 2013